Metabolomics in premature labor: A novel approach to identify patients at risk for preterm delivery

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 12, 2010, Pages 1344-1359

  Romero, Roberto ^a,b   Mazaki Tovi, Shali ^a,b   Vaisbuch, Edi ^a,b   Kusanovic, Juan Pedro ^a,b   Chaiworapongsa, Tinnakorn ^a,b   Gomez, Ricardo ^c   Nien, Jyh Kae ^c   Yoon, Bo Hyun ^d   Mazor, Moshe ^e   Luo, Jingqin ^f   Banks, David ^g   Ryals, John ^h   Beecher, Chris ^h  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^d Seoul National University College of Medicine   (South Korea)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY   (United States)

^h METABOLON INC   (United States)

Author keywords

amniocentesis; chorioamnionitis; cytokines; high dimensional biology; intraamniotic infection; intraamniotic inflammation; MIAC; microbial invasion of the amniotic cavity; omics sciences; pregnancy; preterm delivery; Preterm labor

Indexed keywords

6 N METHYLADENINE; ACEGLUTAMIDE; ARACHIDIC ACID; CATECHOL; CHOLESTEROL; FRUCTOSE; GALACTOSE; GLUTAMIC ACID; GLYCEROL; GLYCINE; HEXOSE; INOSITOL; ISOLEUCINE; LEUCINE; MANNOSE; METHIONINE; PHENYLALANINE; PHENYLETHANOLAMINE; PIMELIC ACID; SALICYLAMIDE; SUCCINIC ACID; TRYPTOPHAN; XENOBIOTIC AGENT;

ADOLESCENT; ADULT; ALGORITHM; AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; AMNIONITIS; ARTICLE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLOMICS; PATIENT CODING; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; TISSUE PREPARATION; UTERUS CONTRACTION;

ADOLESCENT; ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; CHORIOAMNIONITIS; CROSS-SECTIONAL STUDIES; FEMALE; FOURIER ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GESTATIONAL AGE; HUMANS; MASS SPECTROMETRY; METABOLOMICS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78349238952     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.482618     Document Type: Article

References (251)

1. Romero R. The child is the father of the man. Prenat Neonat Med 1996;8-11.
2. Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med 2009; 22:633-635.
3. Romero R. Prenatal medicine: the child is the father ofthe man. J Matern Fetal Neonatal Med 2009;22:636-639.
4. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006;113 (Suppl 3):17-42.
5. Esplin MS, Romero R, Chaiworapongsa T, Kim YM, Edwin S, Gomez R, Mazor M, Adashi EY. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection. J Matern Fetal Neonatal Med 2005;17:365-373.
6. Soto E, Espinoza J, Nien JK, Kusanovic JP, Erez O, Richani K, Santolaya-Forgas J, Romero R. Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2007;20: 15-22.
7. Chaiworapongsa T, Hong JS, Hull WM, Romero R, Whitsett JA. Amniotic fluid concentration of surfactant proteins in intra-amniotic infection. J Matern Fetal Neonatal Med 2008; 21:663-670.
8. Chaiworapongsa T, Erez O, Kusanovic JP, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Than NG, Mittal P, Kim YM, Camacho N, et al. Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition. J Matern Fetal Neonatal Med 2008; 21:449-461.
9. Gotsch F, Romero R, Chaiworapongsa T, Erez O, Vaisbuch E, Espinoza J, Kusanovic JP, Mittal P, Mazaki-Tovi S, Kim CJ, et al. Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturi-tion. J Matern Fetal Neonatal Med 2008;21:605-616.
10. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiwor-apongsa T, et al. The anti-inflammatory limb ofthe immune response in preterm labor, intra-amniotic infection/inflam-mation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008;21:529-547.
11. Hamill N, Romero R, Gotsch F, Kusanovic JP, Edwin S, Erez O, Than NG, Mittal P, Espinoza J, Friel LA, et al. Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. J Perinat Med 2008;36:217-227.
12. Kusanovic JP, Romero R, Mazaki-Tovi S, Chaiworapongsa T, Mittal P, Gotsch F, Erez O, Vaisbuch E, Edwin SS, Than NG, et al. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med 2008;21:902-916.
13. Lee SE, Romero R, Park CW, Jun JK, Yoon BH. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol 2008;198:633-638.
14. Lee SE, Romero R, Park IS, Seong HS, Park CW, Yoon BH. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008;21:89-94.
15. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Mittal P, Than NG, Nhan-Chang CL, Hamill N, Vaisbuch E, et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture ofmembranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008;36:485-496.
16. Mittal P, Romero R, Kusanovic JP, Edwin SS, Gotsch F, Mazaki-Tovi S, Espinoza J, Erez O, Nhan-Chang CL, Than NG, et al. CXCL6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. Am J Reprod Immunol 2008;60:246-257.
17. Romero R, Espinoza J, Hassan S, Gotsch F, Kusanovic JP, Avila C, Erez O, Edwin S, Schmidt AM. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med 2008;36:388-398.
18. Vaisbuch E, Romero R, Erez O, Kusanovic JP, Gotsch F, Than NG, Mazaki-Tovi S, Mittal P, Edwin S, Hassan SS. Total hemoglobin concentration in amniotic fluid is in-creased in intraamniotic infection/inflammation. Am J Obstet Gynecol 2008;199:426-427.
19. Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiwor-apongsa T, Mazaki-Tovi S, Mittal P, Ogge G, Gotsch F, Erez O, et al. Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation. J Perinat Med 2010;38:161-171.
20. Erez O, Romero R, Vaisbuch E, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Gotsch F, Gomez R, Maymon E, Pacora P, et al. Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with pre-term labor: evidence of an increased thrombin generation. J Matern Fetal Neonatal Med 2009;22:1-12.
21. Kusanovic JP, Romero R, Jodicke C, Mazaki-Tovi S, Vaisbuch E, Erez O, Mittal P, Gotsch F, Chaiworapongsa T, Edwin SS, et al. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009;19626565:1-16.
22. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Erez O, Mittal P, Gotsch F, Chaiworapongsa T, Than NG, Kim SK, et al. Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009;19591073:1-11.
23. Pacora P, Romero R, Chaiworapongsa T, Kusanovic JP, Erez O, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Jai KC, Than NG, et al. Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation. J Perinat Med 2009;37:503-511.
24. Romero R, Pedro KJ, Munoz H, Gomez R, Lamont RF, Yeo L. Allergy-induced preterm labor after the ingestion of shellfish. J Matern Fetal Neonatal Med 2010;23:351-359.
25. Romero R, Kusanovic JP, Gomez R, Lamont R, Bytautiene E, Garfield RE, Mittal P, Hassan SS, Yeo L. The clinical significance of eosinophils in the amniotic fluid in preterm labor. J Matern Fetal Neonatal Med 2010;23:320-329.
26. Soto E, Romero R, Richani K, Yoon BH, Chaiworapongsa T, Vaisbuch E, Mittal P, Erez O, Gotsch F, Mazor M, et al. Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection. J Matern Fetal Neonatal Med 2009;22:983-992.
27. Vaisbuch E, Romero R, Erez O, Mazaki-Tovi S, Pedro KJ, Soto E, Gotsch F, Dong Z, Chaiworapongsa T, Kim SK, et al. Fragment Bb in amniotic fluid: evidence for comple-ment activation by the alternative pathway in women with intra-amniotic infection/inflammation. J Matern Fetal Neo-natal Med 2009;22:905-916.
28. Vaisbuch E, Kusanovic JP, Erez O, Mazaki-Tovi S, Gotsch F, Kim CJ, Kim JS, Chaiworapongsa T, Edwin S, Than NG, et al. Amniotic fluid fetal hemoglobin in normal pregnancies and pregnancies complicated with preterm labor or prelabor rupture of membranes. J Matern Fetal Neonatal Med 2009;22:388-397.
29. Kusanovic JP, Romero R, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Vaisbuch E, Erez O, Gotsch F, Gabor TN, Edwin SS, et al. Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010;23:34-47.
30. Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, Erez O, Nandor GT, Kim SK, Dong Z, Gotsch F, Mittal P, Chaiworapongsa T, et al. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010;23:111-119.
31. Chaiworapongsa T, Romero R, Tarca A, Pedro KJ, Mittal P, Kwon KS, Gotsch F, Erez O, Vaisbuch E, Mazaki-Tovi S, et al. A subset ofpatients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med 2009;22:1122-1139.
32. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, et al. Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonatal Med 2009;22:887-904.
33. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Chaiwor-apongsa T, Mittal P, Kim SK, Pacora P, Gotsch F, Dong Z, et al. Maternal plasma visfatin in preterm labor. J Matern Fetal Neonatal Med 2009;22:693-704.
34. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epide-miology and causes ofpreterm birth. Lancet 2008;371:75-84.
35. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Pineles BL, Gotsch F, Mittal P, Than NG, Espinoza J, Hassan SS. Recurrent preterm birth. Semin Perinatol 2007;31:142-158.
36. Kim JS, Romero R, Cushenberry E, Kim YM, Erez O, Nien JK, Yoon BH, Espinoza J, Kim CJ. Distribution ofCD14+ and CD68+ macrophages in the placental bed and basal plate of women with preeclampsia and preterm labor. Placenta 2007;28:571-576.
37. Chaiworapongsa T, Romero R, Espinoza J, Kim YM, Edwin S, Bujold E, Gomez R, Kuivaniemi H. Macrophage migration inhibitory factor in patients with preterm parturi-tion and microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2005;18:405-416. (Pubitemid 43062395)
38. Nathanielsz PW. A time to be born: implications ofanimal studies in maternal-fetal medicine. Birth 1994;21:163-169.
39. Lappas M, Permezel M, Georgiou HM, Rice GE. Type II phospholipase A2 in preterm human gestational tissues. Placenta 2001;22:64-69.
40. Bethin KE, Nagai Y, Sladek R, Asada M, Sadovsky Y, Hudson TJ, Muglia LJ. Microarray analysis of uterine gene expression in mouse and human pregnancy. Mol Endocrinol 2003;17:1454-1469.
41. Meadows JW, Eis AL, Brockman DE, Myatt L. Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J Clin Endocrinol Metab 2003;88:433-439.
42. Mitchell MD, Simpson KL, Keelan JA. Paradoxical proin-flammatory actions of interleukin-10 in human amnion: potential roles in term and preterm labour. J Clin Endocrinol Metab 2004;89:4149-4152.
43. Maul H, Mackay L, Garfield RE. Cervical ripening: biochemical, molecular, and clinical considerations. Clin Obstet Gynecol 2006;49:551-563.
44. Bruni L, Luisi S, Ferretti C, Janneau JL, Quadrifoglio M, Richon S, Dangles-Marie V, Bellet D, Petraglia F. Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy. Am J Obstet Gynecol 2007;197:606-604.
45. Maner WL, Garfield RE. Identification of human term and preterm labor using artificial neural networks on uterine electromyography data. Ann Biomed Eng 2007;35:465-473.
46. Blank V, Hirsch E, Challis JR, Romero R, Lye SJ. Cytokine signaling, inflammation, innate immunity and preterm labour-aworkshopreport. Placenta 2008;29 (Suppl A):S102-S104.
47. Casciani V, Premyslova M, Luo D, Marinoni E, Moscarini M, Di Iorio R, Challis JR. Effect of calcium ionophore A23187 on prostaglandin synthase type 2 and 15-hydroxy-prostaglandin dehydrogenase expression in human chorion trophoblast cells. Am J Obstet Gynecol 2008;199:554-558.
48. Shynlova O, Tsui P, Dorogin A, Lye SJ. Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J Immunol 2008;181:1470-1479.
49. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F. Inflammation and pregnancy. Reprod Sci 2009;16:206-215.
50. Lappas M, Rice GE. Transcriptional regulation of the processes of human labour and delivery. Placenta 2009;30 (Suppl A):S90-S95.
51. Stella CL, Bennett MR, Devarajan P, Greis K, Wyder M, Macha S, Rao M, Jodicke C, Moussa H, How HY, et al. Preterm labor biomarker discovery in serum using 3 proteomic profiling methodologies. Am J Obstet Gynecol 2009;201:387-413.
52. Leguizamon G, Smith J, Younis H, Nelson DM, Sadovsky Y. Enhancement of amniotic cyclooxygenase type 2 activity in women with preterm delivery associated with twins or polyhydramnios. Am J Obstet Gynecol 2001;184:117-122.
53. Hirsch E, Goldstein M, Filipovich Y, Wang H. Placental expression ofenzymes regulating prostaglandin synthesis and degradation. Am J Obstet Gynecol 2005;192:1836-1842.
54. Bastek JA, Sammel MD, Pare E, Srinivas SK, Posencheg MA, Elovitz MA. Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol 2008;199:367-368.
55. Elovitz MA, Gonzalez J. Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth. J Matern Fetal Neonatal Med 2008;21:223-230.
56. Simhan HN, Krohn MA. Paternal race and preterm birth. Am J Obstet Gynecol 2008;198:644-646.
57. Filipovich Y, Lu SJ, Akira S, Hirsch E. The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am J Obstet Gynecol 2009;200:93-98.
58. Simhan HN, Krohn MA. First-trimester cervical inflamma-tory milieu and subsequent early preterm birth. Am J Obstet Gynecol 2009;200:377-374.
59. Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001;185:1059-1063.
60. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad A, Das A, Miodovnik M, Vandorsten PJ, Caritis SN, Thurnau G, et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 2001;185:643-651. (Pubitemid 32862554)
61. Iams JD, Goldenberg RL, Mercer BM, Moawad AH, Meis PJ, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, et al. The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 2001;184:652-655.
62. Goldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F. What we have learned about the predictors of preterm birth. Semin Perinatol 2003;27:185-193.
63. Kalish RB, Vardhana S, Normand NJ, Gupta M, Witkin SS. Association of a maternal CD14-159 gene polymorphism with preterm premature rupture of membranes and sponta-neous preterm birth in multi-fetal pregnancies. J Reprod Immunol 2006;70:109-117.
64. Diamond AK, Sweet LM, Oppenheimer KH, Bradley DF, Phillippe M. Modulation ofmonocyte chemotactic protein-1 expression during lipopolysaccharide-induced preterm de-livery in the pregnant mouse. Reprod Sci 2007;14:548-559.
65. Chaves JH, Babayan A, Bezerra CM, Linhares IM, Witkin SS. Maternal and neonatal interleukin-1 receptor antagonist geno-type and pregnancy outcome in a population with a high rate of pre-termbirth. Am J Reprod Immunol 2008; 60:312-317.
66. Iams JD, Romero R, Culhane JF, Goldenberg RL. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality ofpreterm birth. Lancet 2008;371:164-175.
67. Ratajczak CK, Muglia LJ. Insights into parturition biology from genetically altered mice. Pediatr Res 2008;64:581-589.
68. Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev 2009;CD007235.
69. Carlin A, Norman J, Cole S, Smith R. Tocolytics and preterm labour. BMJ 2009;338:b195.
70. Defranco EA, Chang JJ, Macones GA, Muglia LJ. The correlation in birth timing between singleton and twin gestations in the same mother. J Matern Fetal Neonatal Med 2009;22:106-110.
71. Scheib S, Visintine JF, Miroshnichenko G, Harvey C, Rychlak K, Berghella V. Is cerclage height associated with the incidence ofpreterm birth in women with an ultrasound-indicated cerclage? Am J Obstet Gynecol 2009;200:e12-e15.
72. Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, Bisits AM, McElduff P, Giles WB, Smith DW. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab 2009;94:2066-2074.
73. Nien JK, Yoon BH, Espinoza J, Kusanovic JP, Erez O, Soto E, Richani K, Gomez R, Hassan S, Mazor M, et al. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol 2006; 195:1025-1030.
74. Romero R, Espinoza J, Gotsch F, Kusanovic JP Friel LA Erez O Mazaki-Tovi S Than NG Hassan S Tromp G. The use ofhigh-dimensional biology (genomics transcriptomics proteomics and metabolomics) to understand the preterm parturition syndrome. BJOG 2006; 113: (suppl 3) 118-135.
75. Romero R, Tromp G. High-dimensional biology in obste-trics and gynecology: functional genomics in microarray studies. Am J Obstet Gynecol 2006;195:360-363.
76. Evans GA. Designer science and the "omic" revolution. Nat Biotechnol 2000;18:127.
77. Gracey AY, Cossins AR. Application of microarray technol-ogy in environmental and comparative physiology. Annu Rev Physiol 2003;65:231-259.
78. Mehta T, Tanik M, Allison DB. Towards sound epistemo-logical foundations of statistical methods for high-dimen-sional biology. Nat Genet 2004;36:943-947.
79. Weinstein JN. Fishing expeditions. Science 1998;282:628-629.
80. Weinstein JN. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr Opin Pharmacol 2002;2:361-365.
81. Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001;286:2322-2324.
82. Collins FS, Mansoura MK. The Human Genome Project. Revealing the shared inheritance of all humankind. Cancer 2001;91:221-225.
83. Ginsburg GS, McCarthy JJ. Personalized medicine: revolu-tionizing drug discovery and patient care. Trends Biotechnol 2001;19:491-496.
84. McKusick VA. The anatomy of the human genome: a neo-Vesalian basis for medicine in the 21st century. JAMA 2001;286:2289-2295.
85. Subramanian G, Adams MD, Venter JC, Broder S. Implications ofthe human genome for understanding human biology and medicine. JAMA 2001;286:2296-2307.
86. Hegde PS, White IR, Debouck C. Interplay oftranscriptomics and proteomics. Curr Opin Biotechnol 2003;14:647-651.
87. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complemen-tary DNA microarray. Science 1995;270:467-470.
88. Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, Shah N, Shen N, Yang R, Fodor SP. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 1995;19: 442-447.
89. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577. (Pubitemid 34178440)
90. Phizicky E, Bastiaens PI, Zhu H, Snyder M, Fields S. Protein analysis on a proteomic scale. Nature 2003;422:208-215.
91. Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 2003;44:1071-1079.
92. Lagarde M, Geloen A, Record M, Vance D, Spener F. Lipidomics is emerging. Biochim Biophys Acta 2003; 1634:61.
93. Wenk MR. The emerging field oflipidomics. Nat Rev Drug Discov 2005;4:594-610.
94. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understand-ing global metabolite data. Trends Biotechnol 2004;22:245-252.
95. Jain S, Jayasimhulu K, Clark JF. Metabolomic analysis of molecular species of phospholipids from normotensive and preeclamptic human placenta electrospray ionization mass spectrometry. Front Biosci 2004;9:3167-3175.
96. Nobeli I, Thornton JM. A bioinformatician's view of the metabolome. Bioessays 2006;28:534-545.
97. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007;35:D521-D526.
98. Rochfort S. Metabolomics reviewed: a new "omics" plat-form technology for systems biology and implications for natural products research. J Nat Prod 2005;68:1813-1820.
99. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, Bienvenut WV, Lemery D, Quadroni M, Dastugue B, et al. Identification of biologic markers of the premature rupture offetal membranes: proteomic approach. Proteomics 2003;3:1521-1525.
100. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, McCormack A, Lapidus JA, Hitti J, Eschenbach DA, et al. Diagnosis ofintra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004;292:462-469.
101. Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, Jacobsson B. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res 2005;4:2236-2242.
102. Cobo T, Palacio M, Navarro-Sastre A, Ribes A, Bosch J, Filella X, Gratacos E. Predictive value ofcombined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol 2009;200:499-496.
103. Shah SJ, Yu KH, Sangar V, Parry SI, Blair IA. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry. J Proteome Res 2009;8:2407-2417.
104. Horgan RP, Clancy OH, Myers JE, Baker PN. An overview of proteomic and metabolomic technologies and their applica-tion to pregnancy research. BJOG 2009;116:173-181.
105. Bujold E, Romero R, Kusanovic JP, Erez O, Gotsch F, Chaiworapongsa T, Gomez R, Espinoza J, Vaisbuch E, Mee KY, et al. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med 2008;21:697-713.
106. Klein LL, Jonscher KR, Heerwagen MJ, Gibbs RS, McManaman JL. Shotgun proteomic analysis of vaginal fluid from women in late pregnancy. Reprod Sci 2008;15: 263-273.
107. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007;6:1406-1415.
108. Dasari S, Pereira L, Reddy AP, Michaels JE, Lu X, Jacob T, Thomas A, Rodland M, Roberts CT Jr, Gravett MG, et al. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 2007;6:1258-1268. (Pubitemid 46724022)
109. Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, Lapidus JA, Lu X, Rodland M, Roberts CT Jr, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007;6:1269-1276.
110. Di Quinzio MK, Oliva K, Holdsworth SJ, Ayhan M, Walker SP, Rice GE, Georgiou HM, Permezel M. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust N Z J Obstet Gynaecol 2007;47:9-15.
111. Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, Espinoza J, Chaiworapongsa T, Gonzalez R, Iams JD, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007;20:167-173.
112. Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanaoka S, Hagay Z, Merchant L, Hobbins JC. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991; 165:821-830.
113. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, Jun JK. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130-1136. (Pubitemid 33097376)
114. Romero R, Emamian M, Quintero R, Wan M, Hobbins JC, Mazor M, Edberg S. The value and limitations ofthe Gram stain examination in the diagnosis ofintraamniotic infection. Am J Obstet Gynecol 1988;159:114-119.
115. Romero R, Jimenez C, Lohda AK, Nores J, Hanaoka S, Avila C, Callahan R, Mazor M, Hobbins JC, Diamond MP. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990;163:968-974.
116. Andreoli R, Manini P, Poli D, Bergamaschi E, Mutti A, Niessen WM. Development of a simplified method for the simultaneous determination ofretinol, alpha-tocopherol, and beta-carotene in serum by liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Anal Bioanal Chem 2004;378:987-994.
117. Gehrke CW, Leimer K. Trimethylsilylation of amino acids derivatization and chromatography. J Chromatogr 1971;57: 219-238.
118. Evans AM, Dehaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chro-matography/electrospray ionization tandem mass spectro-metry platform for the identification and relative quantification of the small-molecule complement ofbiologi-cal systems. Anal Chem 2009;81:6656-6667.
119. Liaw A, Wiener M. Classication and regression by random forest. R News 2002;2:18-22.
120. Breiman L. Technical note: some properties of splitting criteria. Mach Learn 1966;24:41-47.
121. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
122. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
123. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007;50:652-683.
124. Madsen-Bouterse SA, Romero R, Tarca AL, Kusanovic JP, Espinoza J, Kim CJ, Kim JS, Edwin SS, Gomez R, Draghici S. The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 2010;63:73-92.
125. Yoon BH, Romero R, Jun JK, Maymon E, Gomez R, Mazor M, Park JS. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1998;179:1107-1114.
126. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-681.
127. Fitzgerald MJ, Goto M, Myers TF, Zeller WP. Early metabolic effects of sepsis in the preterm infant: lactic acidosis and increased glucose requirement. J Pediatr 1992;121:951-955.
128. Yeung CY. Hypoglycemia in neonatal sepsis. J Pediatr 1970;77:812-817.
129. Yeung CY, Lee VW, Yeung CM. Glucose disappearance rate in neonatal infection. J Pediatr 1973;82:486-489.
130. Leake RD, Fiser RH Jr, Oh W. Rapid glucosedisappearance in infantswithinfection. Clin Pediatr (Phila) 1981;20:397-401.
131. Long CL, Jeevanandam M, Kim BM, Kinney JM. Whole body protein synthesis and catabolism in septic man. Am J Clin Nutr 1977;30:1340-1344.
132. Cerra FB, Siegel JH, Coleman B, Border JR, McMenamy RR. Septic autocannibalism. A failure of exogenous nutri-tional support. Ann Surg 1980;192:570-580.
133. Regnault TR, de Vrijer B, Battaglia FC. Transport and metabolism of amino acids in placenta. Endocrine 2002;19:23-41.
134. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817-824.
135. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990;85:1392-1400.
136. Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, Baumann P, Araneda H, Kenney JS, Cotton DB, et al. A comparative study ofthe diagnostic performance ofamniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture ofmembranes. Am J Obstet Gynecol 1993;169:839-851.
137. Gomez R, Romero R, Galasso M, Behnke E, Insunza A, Cotton DB. The value ofamniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis ofmicrobial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994;32:200-210.
138. Wasz-Hockert O, Brander E, Paatela M. Reduced concentra-tion ofcerebrospinal fluid glucose in tuberculous meningitis; experimental studies. Ann Paediatr Fenn 1956;2:320-326.
139. Levinsky WJ. Hypoglycorrhachia (low cerebrospinal-fluid sugar) in diffuse meningeal neoplasm. N Engl J Med 1963;268:198-199.
140. Owen DS. Synovial fluid glucose. JAMA 1978;239:193.
141. Murray PA, Kern DG, Winkler JR. Identification of a galactose-binding lectin on Fusobacterium nucleatum FN-2. Infect Immunol 1988;56:1314-1319.
142. Smith PF. Detection of lipoglycans in ureaplasmas. JBacteriol 1985;162:611-614.
143. Petty HR, Kindzelskii AL, Chaiworapongsa T, Petty AR, Romero R. Oxidant release is dramatically increased by elevated glucose concentrations in neutrophils from pregnant women. J Matern Fetal Neonatal Med 2005;18:397-404.
144. Cheng X. Structure and function of DNA methyltrans-ferases. Annu Rev Biophys Biomol Struct 1995;24:293-318.
145. Barbeyron T, Kean K, Forterre P. DNA adenine methyla-tion of GATC sequences appeared recently in the Escherichia coli lineage. J Bacteriol 1984;160:586-590.
146. Wion D, Casadesus J. N6-methyl-adenine: an epigenetic signal for DNA-protein interactions. Nat Rev Microbiol 2006;4:183-192.
147. Tavazzi B, Lazzarino G, Leone P, Amorini AM, Bellia F, Janson CG, Di P, Ceccarelli L, Donzelli S, Francis JS, et al. Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem 2005;38:997-1008.
148. Gardon M, Pinheiro CB, Chapuis G. Structural phases of hexamethylenetetramine-pimelic acid (1/1): a unified de-scription based on a stacking model. Acta Crystallogr B 2003;59:527-536.
149. Hoare DS, Work E. The stereoisomers of alpha epsilon-diaminopimelic acid. II. Their distribution in the bacterial orderActinomycetales and in certain Eubacteriales. Biochem J 1957;65:441-447.
150. Scapin G, Blanchard JS. Enzymology of bacterial lysine biosynthesis. Adv Enzymol Relat Areas Mol Biol 1998;72: 279-324.
151. Cox RJ. The DAP pathway to lysine as a target for antimicrobial agents. Nat Prod Rep 1996;13:29-43.
152. Born TL, Blanchard JS. Structure/function studies on enzymes in the diaminopimelate pathway of bacterial cell wall biosynthesis. Curr Opin Chem Biol 1999;3:607-613.
153. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003;4:702-707.
154. Schleifer KH, Kandler O. Peptidoglycan types ofbacterial cell walls and their taxonomic implications. Bacteriol Rev 1972;36:407-477.
155. Lee SE, Park IS, Romero R, Yoon BH. Amniotic fluid prostaglandin F2 increases even in sterile amniotic fluid and is an independent predictor ofimpending delivery in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2009;22:880-886.
156. Mitchell MD, Chang MC, Chaiworapongsa T, Lan HY, Helliwell RJ, Romero R, Sato TA. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. J Clin Endocrinol Metab 2005;90:4244-4248.
157. Edwin SS, Romero RJ, Munoz H, Branch DW, Mitchell MD. 5-Hydroxyeicosatetraenoic acid and human parturi-tion. Prostaglandins 1996;51:403-412.
158. Romero R, Baumann P, Gomez R, Salafia C, Rittenhouse L, Barberio D, Behnke E, Cotton DB, Mitchell MD. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and throm-boxane B2 in term pregnancy. Am J Obstet Gynecol 1993;168:1654-1664.
159. Romero R, Wu YK, Sirtori M, Oyarzun E, Mazor M, Hobbins JC, Mitchell MD. Amniotic fluid concentrations of prostaglandin F2 alpha, 13,14-dihydro-15-keto- prostaglan-din F2 alpha (PGFM) and 11-deoxy-13,14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2 (PGEM-LL) in preterm labor. Prostaglandins 1989;37:149-161.
160. Romero R, Wu YK, Mazor M, Hobbins JC, Mitchell MD. Amniotic fluid prostaglandin E2 in preterm labor. Prosta-glandins Leukot Essent Fatty Acids 1988;34:141-145.
161. Romero R, Wu YK, Mazor M, Hobbins JC, Mitchell MD. Amniotic fluid 5-hydroxyeicosatetraenoic acid in preterm labor. Prostaglandins 1988;36:179-189.
162. Romero R, Emamian M, Wan M, Quintero R, Hobbins JC, Mitchell MD. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1461-1467. (Pubitemid 18022877)
163. Romero R, Emamian M, Quintero R, Wan M, Hobbins JC, Mitchell MD. Amniotic fluid prostaglandin levels and intra-amniotic infections. Lancet 1986;1:1380.
164. Romero R, Quintero R, Emamian M, Wan M, Grzyboski C, Hobbins JC, Mitchell MD. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1454-1460. (Pubitemid 18022876)
165. Romero R, Wu YK, Mazor M, Oyarzun E, Hobbins JC, Mitchell MD. Amniotic fluid arachidonate lipoxygenase metabolites in preterm labor. Prostaglandins Leukot Essent Fatty Acids 1989;36:69-75.
166. Romero R, Emamian M, Wan M, Grzyboski C, Hobbins JC, Mitchell MD. Increased concentrations ofarachidonic acid lipoxygenase metabolites in amniotic fluid during parturi-tion. Obstet Gynecol 1987;70:849-851.
167. Tromp G, Kuivaniemi H, Romero R, Chaiworapongsa T, Kim YM, Kim MR, Maymon E, Edwin S. Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes. Am J Obstet Gynecol 2004;191:1331-1338.
168. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105:20458-20463.
169. Breuiller-Fouche M, Charpigny G, Germain G. Functional genomics of the pregnant uterus: from expectations to reality, a compilation of studies in the myometrium. BMC Pregn Childbirth 2007;7 (Suppl 1):S4.
170. Dolan S, Biermann J, Damus K. Genomics for health in preconception and prenatal periods. J Nurs Scholarsh 2007;39:4-9.
171. Wilson RD. Genomics: new technology for obstetrics. J Obstet Gynaecol Can 2005;27:63-75.
172. South ST, Chen Z, Brothman AR. Genomic medicine in prenatal diagnosis. Clin Obstet Gynecol 2008;51:62-73.
173. Solomon BD, Jack BW, Feero WG. The clinical content of preconception care: genetics and genomics. Am J Obstet Gynecol 2008;199:S340-S344.
174. Kim JS, Romero R, Tarca AL, La Jeunesse C, Han YM, Kim MJ, Suh YL, Draghici S, Mittal P, Gotsch F, et al. Gene expression profiling demonstrates a novel role for foetal fibrocytes and the umbilical vessels in human fetoplacental development. J Cell Mol Med 2008;12:1317-1330.
175. Knox K, Baker JC. Genomic evolution ofthe placenta using co-option and duplication and divergence. Genome Res 2008;18:695-705.
176. Toft JH, Lian IA, Tarca AL, Erez O, Espinoza J, Eide IP, Bjorge L, Draghici S, Romero R, Austgulen R. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J Matern Fetal Neonatal Med 2008;21:267-273.
177. Buffat C, Mondon F, Rigourd V, Boubred F, Bessieres B, Fayol L, Feuerstein JM, Gamerre M, Jammes H, Rebourcet R, et al. Ahierarchical analysis of transcriptome alterations in intrauterine growth restriction (IUGR) reveals common pathophysiological pathways in mammals. J Pathol 2007; 213:337-346.
178. Hassan SS, Romero R, Tarca AL, Draghici S, Pineles B, Bugrim A, Khalek N, Camacho N, Mittal P, Yoon BH, et al. Signature pathways identified from gene expression profiles in the human uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2007;197:250-257.
179. Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J Immunol 2007;179:557-565.
180. Timmons BC, Mahendroo M. Processes regulating cervical ripening differ from cervical dilation and postpartum repair: insights from gene expression studies. Reprod Sci 2007;14:53-62.
181. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, Chang YJ, Wang CN, Peng HH, Chang YL, Chao AS, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007;25:2511-2523.
182. Buimer M, Keijser R, Jebbink JM, Wehkamp D, van Kampen AH, Boer K, van der Post JA, Ris-Stalpers C. Seven placental transcripts characterize HELLP-syndrome. Placenta 2008;29:444-453.
183. Gielchinsky Y, Bogoch Y, Rechavi G, Jacob-Hirsch J, Amariglio N, Shveiky D, Linial M, Laufer N. Gene expression in women conceiving spontaneously over the age of45 years. Fertil Steril 2008;89:1641-1650.
184. Kang BY, Tsoi S, Zhu S, Su S, Kay HH. Differential gene expression profiling in HELLP syndrome placentas. Reprod Sci 2008;15:285-294.
185. Sitras V, Paulssen RH, Gronaas H, Vartun A, Acharya G. Gene expression profile in labouring and non-labouring human placenta near term. Mol Hum Reprod 2008;14:61-65.
186. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009;200:206-213.
187. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA 2009;106:9425-9429.
188. Marvin KW, Keelan JA, Eykholt RL, Sato TA, Mitchell MD. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod 2002;8:399-408.
189. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002;8:674-680.
190. Gross SJ, Ferreira JC, Morrow B, Dar P, Funke B, Khabele D, Merkatz I. Gene expression profile of trisomy 21 placentas: a potential approach for designing noninvasive techniques of prenatal diagnosis. Am J Obstet Gynecol 2002;187:457-462.
191. Havelock JC, Keller P, Muleba N, Mayhew BA, Casey BM, Rainey WE, Word RA. Human myometrial gene expression before and during parturition. Biol Reprod 2005;72:707-719.
192. Huber A, Hudelist G, Czerwenka K, Husslein P, Kubista E, Singer CF. Gene expression profiling of cervical tissue during physiological cervical effacement. Obstet Gynecol 2005;105:91-98.
193. Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman JM, Kozhich OA, Larsson I, Marsal K, Medstrand P, et al. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 2006;12:169-179.
194. Zhou R, Zhu Q, Wang Y, Ren Y, Zhang L, Zhou Y. Genomewide oligonucleotide microarray analysis on placen-tae of pre-eclamptic pregnancies. Gynecol Obstet Invest 2006;62:108-114.
195. Breuiller-Fouche M, Germain G. Gene and protein expres-sion in the myometrium in pregnancy and labor. Reproduc-tion 2006;131:837-850.
196. Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, Mazor M, Romero R. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006;195(2):394.e1-24.
197. Hassan SS, Romero R, Haddad R, Hendler I, Khalek N, Tromp G, Diamond MP, Sorokin Y, Malone J Jr. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006; 195:778-786.
198. Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 2007;148: 1059-1079.
199. Hampton T. Comprehensive "proteomic profile" ofamnio-tic fluid may aid prenatal diagnosis. JAMA 2007;298:1751.
200. Hassan MI, Kumar V, Singh TP, Yadav S. Proteomic analysis of human amniotic fluid from Rh(\) pregnancy. Prenat Diagn 2008;28:102-108.
201. Kolialexi A, Tsangaris GT, Papantoniou N, Anagnostopou-los AK, Vougas K, Bagiokos V, Antsaklis A, Mavrou A. Application of proteomics for the identification of differen-tially expressed protein markers for Down syndrome in maternal plasma. Prenat Diagn 2008;28:691-698.
202. Kolialexi A, Mavrou A, Spyrou G, Tsangaris GT. Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev 2008;27:624-634.
203. Park JS, Oh KJ, Norwitz ER, Han JS, Choi HJ, Seong HS, Kang YD, Park CW, Kim BJ, Jun JK, et al. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci 2008;15: 457-468.
204. Reddy CS, Holzgreve W, Hahn S. Detection of new screening markers for fetal aneuploidies in maternal plasma: a proteomic approach. Methods Mol Biol 2008;444:311-326.
205. Zhang Y, Zhang YL, Feng C, Wu YT, Liu AX, Sheng JZ, Cai J, Huang HF. Comparative proteomic analysis of human placenta derived from assisted reproductive technology. Proteomics 2008;8:4344-4356.
206. Baker PN, Myers JE. Preeclamptic toxemia: a disease ripe for proteomic discovery. Expert Rev Proteomics 2009; 6: 107-110.
207. Blankley RT, Robinson NJ, Aplin JD, Crocker IP, Gaskell SJ, Whetton AD, Baker PN, Myers JE. A gel-free quantita-tive proteomics analysis of factors released from hypoxic-conditioned placentae. Reprod Sci 2010;17:247-257.
208. Blankley RT, Gaskell SJ, Whetton AD, Dive C, Baker PN, Myers JE. A proof-of-principle gel-free proteomics strategy for the identification ofpredictive biomarkers for the onset of pre-eclampsia. BJOG 2009;116:1473-1480.
209. Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, McCowan LM, Cooper GJ, North RA. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics 2009;9: 2929-2945.
210. Choolani M, Narasimhan K, Kolla V, Hahn S. Proteomic technologies for prenatal diagnostics: advances and chal-lenges ahead. Expert Rev Proteomics 2009;6:87-101.
211. Colquhoun DR, Goldman LR, Cole RN, Gucek M, Mansharamani M, Witter FR, Apelberg BJ, Halden RU. Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect. Environ Health Perspect 2009;117:832-838.
212. Kolialexi A, Tsangaris GT, Mavrou A. Proteomics in prenatal diagnosis. Expert Rev Proteomics 2009;6:111-113.
213. Kolialexi A, Anagnostopoulos AK, Mavrou A, Tsangaris GT. Application of proteomics for diagnosis of fetal aneuploidies and pregnancy complications. J Proteomics 2009;72:731-739.
214. Robinson JM, Vandre DD, Ackerman WE. Placental proteomics: a shortcut to biological insight. Placenta 2009; 30 (Suppl A):S83-S89.
215. Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, Mazaki-Tovi S, Moser A, Tam S, Leszyk J, Master SR, et al. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010;23:261-280.
216. Wang TH, Chao AS, Chen JK, Chao A, Chang YL, Cheng PJ, Chang SD, Wang HS. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril 2009;92:96-107.
217. Centlow M, Hansson SR, Welinder C. Differential proteome analysis ofthe preeclamptic placenta using optimized protein extraction. J Biomed Biotechnol 2010;2010:458-748.
218. Kolla V, Jeno P, Moes S, Tercanli S, Lapaire O, Choolani M, Hahn S. Quantitative proteomics analysis ofmaternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol 2010;2010: 952047.
219. Cottingham K. The cervical-vaginal fluid proteome and possible biomarkers of preterm birth. J Proteome Res 2007;6:1241-1242.
220. Michaels JE, Dasari S, Pereira L, Reddy AP, Lapidus JA, Lu X, Jacob T, Thomas A, Rodland M, Roberts CT Jr, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J Pro-teome Res 2007;6:1277-1285.
221. Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, Thomas A, Dasari S, Lu X, Lapidus JA, Lambert-Messerlian GM, et al. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. J Proteome Res 2007;6:1245-1257.
222. Gravett MG, Thomas A, Schneider KA, Reddy AP, Dasari S, Jacob T, Lu X, Rodland M, Pereira L, Sadowsky DW, et al. Proteomic analysis ofcervical-vaginal fluid: identifica-tion of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 2007;6:89-96.
223. Crawford JT, Pereira L, Buckmaster J, Gravett MG, Tolosa JE. Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis. J Matern Fetal Neonatal Med 2006;19:667-670.
224. Tsangaris GT, Kolialexi A, Karamessinis PM, Anagnosto-poulos AK, Antsaklis A, Fountoulakis M, Mavrou A. The normal human amniotic fluid supernatant proteome. In Vivo 2006;20:479-490.
225. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, Fountoulakis M. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 2006;6:4410-4419.
226. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY, Baek KH. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 2006;6:3445-3454.
227. Michel PE, Crettaz D, Morier P, Heller M, Gallot D, Tissot JD, Reymond F, Rossier JS. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006;27: 1169-1181.
228. Murphy VE, Johnson RF, Wang YC, Akinsanya K, Gibson PG, Smith R, Clifton VL. Proteomic study of plasma proteins in pregnant women with asthma. Respirology 2006;11:41-48.
229. Thadikkaran L, Crettaz D, Siegenthaler MA, Gallot D, Sapin V, Iozzo RV, Queloz PA, Schneider P, Tissot JD. The role ofproteomics in the assessment of premature rupture of fetal membranes. Clin Chim Acta 2005;360:27-36.
230. Gerton GL, Fan XJ, Chittams J, Sammel M, Hummel A, Strauss JF, Barnhart K. A serum proteomics approach to the diagnosis of ectopic pregnancy. Ann N Y Acad Sci 2004;1022:306-316.
231. Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 2004;4:537-543.
232. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab 2002;87:2431-2434.
233. Deepinder F, Chowdary HT, Agarwal A. Role of metabo-lomic analysis of biomarkers in the management of male infertility. Expert Rev Mol Diagn 2007;7:351-358.
234. Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential ofembryos in women undergoing in vitro fertilization. Fertil Steril 2007;88:1350-1357.
235. Singh R, Sinclair KD. Metabolomics: approaches to asses-sing oocyte and embryo quality. Theriogenology 2007;68 (Suppl 1):S56-S62.
236. Botros L, Sakkas D, Seli E. Metabolomics and its application for non-invasive embryo assessment in IVF. Mol Hum Reprod 2008;14:679-690.
237. Bromer JG, Seli E. Assessment ofembryo viability in assisted reproductive technology: shortcomings of current ap-proaches and the emerging role ofmetabolomics. Curr Opin Obstet Gynecol 2008;20:234-241.
238. Scott R, Seli E, Miller K, Sakkas D, Scott K, Burns DH. Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study. Fertil Steril 2008;90:77-83.
239. Seli E, Botros L, Sakkas D, Burns DH. Noninvasive metabolomic profiling ofembryo culture media using proton nuclear magnetic resonance correlates with reproductive potential of embryos in women undergoing in vitro fertiliza-tion. Fertil Steril 2008;90:2183-2189.
240. Nagy ZP, Jones-Colon S, Roos P, Botros L, Greco E, Dasig J, Behr B. Metabolomic assessment of oocyte viability. Reprod Biomed Online 2009;18:219-225.
241. Revelli A, Delle PL, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40.
242. Royere D, Feuerstein P, Cadoret V, Puard V, Uzbekova S, bies-Tran R, Teusan R, Houlgatte R, Labas V, Guerif F. [Non invasive assessment of embryo quality: proteomics, metabolomics and oocyte-cumulus dialogue]. Gynecol Ob-stet Fertil 2009;37:917-920.
243. Heazell AE, Brown M, Dunn WB, Worton SA, Crocker IP, Baker PN, Kell DB. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta 2008;29:691-698.
244. Dunn WB, Brown M, Worton SA, Crocker IP, Broadhurst D, Horgan R, Kenny LC, Baker PN, Kell DB, Heazell AE. Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic distur-bances related to hypoxia and pre-eclampsia. Placenta 2009;30:974-980.
245. Pearce JM, Krone JT, Pappas AA, Komoroski RA. Analysis of saturated phosphatidylcholine in amniotic fluid by 31P NMR. Magn Reson Med 1993;30:476-484.
246. Clifton MS, Joe BN, Zektzer AS, Kurhanewicz J, Vigneron DB, Coakley FV, Nobuhara KK, Swanson MG. Feasibility of magnetic resonance spectroscopy for evaluating fetal lung maturity. J Pediatr Surg 2006;41:768-773.
247. Bock JL. Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables. Clin Chem 1994;40:56-61.
248. Groenen PM, Engelke UF, Wevers RA, Hendriks JC, Eskes TK, Merkus HM, Steegers-Theunissen RP. High-resolution 1H NMR spectroscopy ofamniotic fluids from spina bifida fetuses and controls. Eur J Obstet Gynecol Reprod Biol 2004;112:16-23.
249. Graca G, Duarte IF, Goodfellow BJ, Barros AS, Carreira IM, Couceiro AB, Spraul M, Gil AM. Potential of NMR spectroscopy for the study of human amniotic fluid. Anal Chem 2007;79:8367-8375.
250. Graca G, Duarte IF, Goodfellow J, Carreira IM, Couceiro AB, Domingues MR, Spraul M, Tseng LH, Gil AM. Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy. Anal Chem 2008;80:6085-6092.
251. Graca G, Duarte IF, Barros AS, Goodfellow BJ, Diaz S, Carreira IM, Couceiro AB, Galhano E, Gil AM. (1)H NMR based metabonomics of human amniotic fluid for the metabolic characterization of fetus malformations. J Pro-teome Res 2009;8:4144-4150.